Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2010 1
2011 5
2012 1
2016 2
2017 2
2019 1
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Overweight is a risk factor for both erosive and non-erosive reflux disease.
Savarino E, Zentilin P, Marabotto E, Bonfanti D, Inferrera S, Assandri L, Sammito G, Gemignani L, Furnari M, Dulbecco P, Savarino V. Savarino E, et al. Among authors: inferrera s. Dig Liver Dis. 2011 Dec;43(12):940-5. doi: 10.1016/j.dld.2011.07.014. Epub 2011 Sep 22. Dig Liver Dis. 2011. PMID: 21944835
Diagnostic accuracy of faecal calprotectin in a symptom-based algorithm for early diagnosis of inflammatory bowel disease adjusting for differential verification bias using a Bayesian approach.
Viola A, Fontana A, Belvedere A, Scoglio R, Costantino G, Sitibondo A, Muscianisi M, Inferrera S, Bruno LM, Alibrandi A, Trifirò G, Fries W. Viola A, et al. Among authors: inferrera s. Scand J Gastroenterol. 2020 Oct;55(10):1176-1184. doi: 10.1080/00365521.2020.1807599. Epub 2020 Aug 24. Scand J Gastroenterol. 2020. PMID: 32838582
A minimum of two years of undertreated primary hypothyroidism, as a result of drug-induced malabsorption of l-thyroxine, may have metabolic and cardiovascular consequences.
Benvenga S, Pantano R, Saraceno G, Lipari L, Alibrando A, Inferrera S, Pantano G, Simone G, Tamà S, Scoglio R, Ursino MG, Simone C, Catalano A, Alecci U. Benvenga S, et al. Among authors: inferrera s. J Clin Transl Endocrinol. 2019 Apr 10;16:100189. doi: 10.1016/j.jcte.2019.100189. eCollection 2019 Jun. J Clin Transl Endocrinol. 2019. PMID: 31011539 Free PMC article.
Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth.
Furnari M, Parodi A, Gemignani L, Giannini EG, Marenco S, Savarino E, Assandri L, Fazio V, Bonfanti D, Inferrera S, Savarino V. Furnari M, et al. Among authors: inferrera s. Aliment Pharmacol Ther. 2010 Oct;32(8):1000-6. doi: 10.1111/j.1365-2036.2010.04436.x. Epub 2010 Aug 18. Aliment Pharmacol Ther. 2010. PMID: 20937045 Free article. Clinical Trial.
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease.
Savarino E, Gemignani L, Pohl D, Zentilin P, Dulbecco P, Assandri L, Marabotto E, Bonfanti D, Inferrera S, Fazio V, Malesci A, Tutuian R, Savarino V. Savarino E, et al. Among authors: inferrera s. Aliment Pharmacol Ther. 2011 Aug;34(4):476-86. doi: 10.1111/j.1365-2036.2011.04742.x. Epub 2011 Jun 14. Aliment Pharmacol Ther. 2011. PMID: 21671968 Free article.
13 results